Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

Gut

Volumn 42, Issue 2, 1998, Pages 166-169

  Van Der Hulst, R W M ^a   Van Der Ende, A ^a   Homan, A ^a   Roorda, P ^a   Dankert, J ^a   Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Duodenal ulcer disease; Gastritis; Helicobacter pylori; Metronidazole resistance; Quadruple therapy

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DUODENUM ULCER; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031899368     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.2.166     Document Type: Article

References (20)

1. Van der Hulst RWM, van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective one year follow up study. Gastroenterology 1997;113:25-30.
2. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89(suppl):116-28.
3. Van der Hulst RWM, Tytgat GNJ. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996;31(suppl 220):10-18.
4. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
5. Van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: review of the world literature. Helicobacter 1996;1:6-19.
6. Noach LA, Langenberg WL, Bertola MA, et al. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994;26:321-7.
7. Penston JG. Review article: Helicobacter pylori eradication: understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-89.
8. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
9. Hosking SW, Ling TKW, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992;305:502-4.
10. European study group on antibiotic susceptibility of Helicobacter pylori: results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992;11:777-81.
11. Weel JFL, van der Hulst RWM, Gerrits Y, et al. Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease. J Clin Microbiol 1996;34:2158-62.
12. Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific Publications.
13. Graham D, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
14. Borody TJ, Andrews P, Fracchia G, et al. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
15. Seppala K, Sipponen P, Nuutinen H, et al. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification. Gastroenterology 1995;108:A216.
16. Carrick J, Lian JX, Daskalopoulos G. Effectiveness of two alternative second line therapies for H. pylon eradication following failure of standard triple therapy [abstract]. Am J Gastroenterol 1994;89:1366.
17. +-ATP-ase within the parietal cell. Biochim Biophys Acta 1984;778:549-58.
18. Smith MA, Edwards DI. Redox potential and oxygen concentration as factors in susceptibility of Helicobacter pylori to nitrohetrocyclic drugs. J Antimicrob Chemother 1995;35:751-64.
19. Edwards DI. Nitroimidazole drug action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 1993;31:9-20.
20. Cederbrant G, Kahlmeter G, L Jungh. Porposed mechanisms for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992;29:115-20.